Role of miR-424 in the carcinogenesis

被引:0
|
作者
Soudeh Ghafouri-Fard
Arian Askari
Bashdar Mahmud Hussen
Mohammad Taheri
Nader Akbari Dilmaghani
机构
[1] Shahid Beheshti University of Medical Sciences,Department of Medical Genetics
[2] Shahid Beheshti University of Medical Sciences,Phytochemistry Research Center
[3] Hawler Medical University,Department of Clinical Analysis, College of Pharmacy
[4] Jena University Hospital,Institute of Human Genetics
[5] Shahid Beheshti University of Medical Sciences,Urology and Nephrology Research Center
[6] Shahid Beheshti University of Medical Sciences,Skull Base Research Center, Loghman Hakim Hospital
来源
关键词
miR-424; Cancer; Biomarker;
D O I
暂无
中图分类号
学科分类号
摘要
Recent studies have revealed the impact of microRNAs (miRNAs) in the carcinogenic process. miR-424 is a miRNA whose role in this process is being to be identified. Experiments in the ovarian cancer, cervical cancer, hepatocellular carcinoma, neuroblastoma, breast cancer, osteosarcoma, intrahepatic cholangiocarcinoma, prostate cancer, endometrial cancer, non-small cell lung cancer, hemangioma and gastric cancer have reported down-regulation of miR-424. On the other hand, this miRNA has been found to be up-regulated in melanoma, laryngeal and esophageal squamous cell carcinomas, glioma, multiple myeloma and thyroid cancer. Expression of this miRNA is regulated by methylation status of its promoter. Besides, LINC00641, CCAT2, PVT1, LIN00657, LINC00511 and NNT-AS1 are among lncRNAs that act as molecular sponges for miR-424, thus regulating its expression. Moreover, several members of SNHG family of lncRNAs have been found to regulate expression of miR-424. This miRNA is also involved in the regulation of E2F transcription factors. The current review aims at summarization of the role of miR-424 in the process of cancer evolution and its impact on clinical outcome of patients in order to find appropriate markers for malignancies.
引用
收藏
页码:16 / 38
页数:22
相关论文
共 50 条
  • [41] Knockdown of lncRNA PVT1 Inhibits Glioma Progression by Regulating miR-424 Expression
    Han, Yanjie
    Li, Xinxin
    He, Fei
    Yan, Jiliang
    Ma, Chunyan
    Zheng, Xiaoli
    Zhang, Jinli
    Zhang, Donghui
    Meng, Cuiping
    Zhang, Zhen
    Ji, Xinying
    ONCOLOGY RESEARCH, 2019, 27 (06) : 681 - 690
  • [42] miR-424(322)/503 cluster orchestrates remodeling of the epithelium in the involuting mammary gland and plays a role in breast cancer development
    Navas, David Llobet
    Barrueco, Ruth Rodriguez
    Silva, Jose
    CANCER RESEARCH, 2014, 74 (19)
  • [43] miR-424在胃癌组织中的表达及其临床意义
    靳枫
    余少康
    王树滨
    李柱
    潘毅贞
    中国医学创新, 2019, 16 (07) : 126 - 129
  • [44] Mir-29c and Mir-424 Are Novel Myeloid Differentiation-Associated MicroRNAs in Acute Promyelocytic Leukemia
    Batliner, Jasmin
    Jenal, Mathias
    Fey, Martin F.
    Tschan, Mario P.
    BLOOD, 2008, 112 (11) : 1149 - 1149
  • [45] Knockdown of LncRNA PVT1 inhibits glioma progression by regulating miR-424 expression
    Han, Y. -J.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 270 - 270
  • [46] miR-424对雌激素受体α表达的抑制作用
    秦玺
    徐小洁
    饶春明
    高凯
    杨琦
    史新昌
    于雷
    周勇
    杨玉帅
    程龙
    叶棋浓
    王军志
    生物技术通讯, 2014, 25 (05) : 653 - 655
  • [47] MiR-424 functions as a tumor suppressor in glioma cells and is down-regulated by DNA methylation
    Chen Jin
    Minhong Li
    Yian Ouyang
    Zhigang Tan
    Yugang Jiang
    Journal of Neuro-Oncology, 2017, 133 : 247 - 255
  • [48] MiR-424 functions as a tumor suppressor in glioma cells and is down-regulated by DNA methylation
    Jin, Chen
    Li, Minhong
    Ouyang, Yian
    Tan, Zhigang
    Jiang, Yugang
    JOURNAL OF NEURO-ONCOLOGY, 2017, 133 (02) : 247 - 255
  • [49] miR-424 targets AKT3 and PSAT1 and has a tumor-suppressive role in human colorectal cancer
    Fang, Yifeng
    Liang, Xiao
    Xu, Junfen
    Cai, Xiujun
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 6537 - 6547
  • [50] An endothelial apelin-FGF link mediated by miR-424 and miR-503 is disrupted in pulmonary arterial hypertension
    Jongmin Kim
    Yujung Kang
    Yoko Kojima
    Janet K Lighthouse
    Xiaoyue Hu
    Micheala A Aldred
    Danielle L McLean
    Hyekyung Park
    Suzy A Comhair
    Daniel M Greif
    Serpil C Erzurum
    Hyung J Chun
    Nature Medicine, 2013, 19 : 74 - 82